BNET Industries
Market Cap:$68.9M
Last Fiscal Year Sales:$48.9M
- Public
- US
Dow Jones Description
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Companys innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCares quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry. The Companys business is divided into two segments: Diagnostic & Biopharmaceutical Products and BioServices. SeraCares Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels, which include the manufacture of products used for quality control of infectious disease testing in hospital and clinical testing labs and blood banks, and by in vitro diagnostic (IVD) manufacturers; and reagents and bioprocessing products, which include the manufacture and supply of biological materials used in the research, development and manufacturing of human and animal diagnostics, therapeutics and vaccines. The BioServices segment includes biobanking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.
Number of Employees 238
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 20
-
SeraCare Life Sciences Lands Multiple Contracts from CDC and NIH to Support HIV Research
-
SeraCare whittles its way from bankrupt to profits
-
SeraCare Life Sciences SRLS Surges After Q3 Profit
-
SeraCare Life Sciences Launches First-to-Market HPV Genotype
-
SeraCare Life Sciences Launches First-to-Market HPV Genotype Performance Panel
News & Analysis
Filter by
seracare life sciences inc. - All News and Analysis
SeraCare: Five Reasons to Buy This Biotech Microcap with Recurrent Revenue
Seeking Alpha
- 2009-08-30
I was an aggressive buyer of high quality smallcap and microcap shares during the past several months. However, recent speculative excesses, and my conviction that another wave of the financial crisis lies just ahead, has led me to take profits now in most of my stock positions. ...
NASDAQ changes status of SeraCare Life Sciences, Inc. and requests additional information from company.
- 2006-03-16
M2 PRESSWIRE-16 March 2006-NASDAQ: NASDAQ changes status of SeraCare Life Sciences, Inc. and requests additional information from companyC1994-2006 M2 COMMUNICATIONS LTD RDATE:15032006 New York - The Nasdaq Stock Market, Inc. (NASDAQ: NDAQ) today announced the trading halt status in SeraCare Life...
Naked Short Web Site Announces ECGI, GIGM, IRBT, IVOW, SRLSE, TKO Have Been Removed From Threshold Lists Today.
- 2006-01-12
M2 PRESSWIRE-12 January 2006-BUYINS.NET: Naked Short Web Site Announces ECGI, GIGM, IRBT, IVOW, SRLSE, TKO Have Been Removed From Threshold Lists TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:12012006 www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...
AGIX, BPA, ERI, HEM, PXPL, SRLSE Have Been Added To Naked Short Lists Today.
- 2006-01-04
M2 PRESSWIRE-4 January 2006-BUYINS.NET: AGIX, BPA, ERI, HEM, PXPL, SRLSE Have Been Added To Naked Short Lists TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:04012006 www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold...
"Stocks on the Rise".
- 2005-05-12
M2 PRESSWIRE-12 May 2005-WallStreetGrapevine: "Stocks on the Rise"C1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 Wall Street, NYC - Today, wallstreetgrapevine.com, named; Martin Nutraceuticals Inc. (Pink Sheets: MTNU), American Pharmaceutical Partners Inc. (Nasdaq NM: APPX), Millennium Pharmaceuticals Inc. (Nasdaq NM: MLNM), and Seracare...
SeraCare to Host First Quarter 2005 Conference Call and Webcast Wednesday, February 9, at 4:30 PM EST
- 2005-02-04
OCEANSIDE, Calif. -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), an innovative developer and provider of human and animal based diagnostic, therapeutic and research products for the life science industry, announced today that it will release its fiscal 2005 first quarter results after the market closes on Wednesday, February 9, 2005,...
SeraCare to Host Fiscal 2004 Conference Call and Webcast Monday, December 13 at 5:00 PM EST
- 2004-12-10
OCEANSIDE, Calif. -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a manufacturer and provider of biological materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs, and research applications, announced today that it will release its fiscal 2004 fourth quarter and year-end results after the market...
SeraCare to Host Conference Call and Webcast Thursday, October 14 At 1:00 PM EDT
- 2004-10-11
OCEANSIDE, Calif. -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a manufacturer and provider of biological materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of therapeutic drugs, and additional research applications, announced today that it will initiate its fiscal 2005 financial guidance prior to the market's opening...
- 1
Industry Transcripts by Seeking Alpha
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
